lessons from the european experience with a(h1n1) 2009 angus nicoll cbe european centre for disease...
TRANSCRIPT
Lessons from the European Experience with A(H1N1) 2009Angus Nicoll CBE European Centre for Disease Prevention and Control
3rd meeting of the National Influenza Centres in the Western Pacific and South East Asian Regions, Beijing
Pandemics of influenza
H7
H5
H9*
1980
1997
Recorded new avian influenzas
1996 2002
1999
2003
1955 1965 1975 1985 1995 2005
H1N1
H2N2
1889Russianinfluenz
aH2N2
H2N2
1957Asian
influenzaH2N2
H3N2
1968Hong Konginfluenza
H3N2
H3N8
1900Old Hong
Kong influenza
H3N8
1918Spanishinfluenza
H1N1
1915 1925 1955 1965 1975 1985 1995 20051895 1905 2010 2015
2009Pandemicinfluenza
H1N1
Recorded human pandemic influenza(early sub-types inferred)
Reproduced and adapted (2009) with permission of Dr Masato Tashiro, Director, Center for Influenza Virus Research, National Institute of Infectious Diseases (NIID), Japan.
Animated slide: Press space bar
H1N1Pandemic
H1N1
The situation could be a lot worse for Europe! (Situation circa summer 2009) A pandemic strain emerging in the
Americas. Immediate virus sharing so rapid
diagnostic and vaccines. Pandemic (H1N1) currently not that
pathogenic. Some seeming residual immunity in a
major large risk group (older people). No known pathogenicity markers. Initially susceptible to oseltamivir. Good data and information coming out of
North America. Arriving in Europe in the summer. Mild presentation in most.
A pandemic emerging in SE Asia
Delayed virus sharing
Based on a more pathogenic strain, e.g. A(H5N1)
No residual immunity
Heightened pathogenicity
Inbuilt antiviral resistance
Minimal data until transmission reached Europe
Arriving in the late autumn or winter
Severe presentation immediately
Contrast with what might have happened — and might still happen!
Some ‘Lessons Learnt ‘ points Five years preparation paid off – for those who did it
But need to operationalise and adapt the plans for this pandemic
The ‘acid tests’ have been crucial e.g. can you distribute antivirals quickly and efficiently ?http://ecdc.europa.eu/en/healthtopics/Pages/Pandemic_Influenza_Assessment_Tools.aspx
Built around a regularly updated risk assessment http://ecdc.europa.eu/en/healthtopics/Documents/0907_Influenza_AH1N1_Risk_Assessment.pdf
Planning projections has to be adjusted http://ecdc.europa.eu/en/healthtopics/Documents/0908_InfluenzaA_H1N1_Planning_Assumptions_for_the_First_Wave_of_Pandemic_A(H1N1)_2009_in_Europe.pdf
Surveillance has had to be adjusted http://ecdc.europa.eu/en/publications/Publications/0908_MER_Surveillance_and_Studies_in_a_Pandemic_Meeting_Report.pdf
Personal interventions - are justified Societal Public Health Interventions – mostly not justified
http://ecdc.europa.eu/en/publications/Publications/0906_TER_Public_Health_Measures_for_Influenza_Pandemics.pdf http://ecdc.europa.eu/en/healthtopics/Documents/0908_InfluenzaA_H1N1_Managing_schools_during_the_current_pandemic_(H1N1)_2009.pdf
Containment vs. Mitigation – beware of policy decisions http://ecdc.europa.eu/en/healthtopics/Documents/0906_Influenza_AH1N1_Mitigation_and_Delaying_Strategies_for_the_Influenza_in_Europe.pdf
Beware of stating numbers – deaths are difficult
The health care sector is a vulnerable point
Idealised national curve for planning, Europe 2009: Reality is never so smooth and simple
Single-wave profile showing proportion of new clinical cases, consultations, hospitalisations or deaths by week. Based on London, second wave 1918.
Source: Department of Health, UK
0%
5%
10%
15%
20%
25%
1 2 3 4 5 6 7 8 9 10 11 12Week
Pro
port
ion
of
tota
l ca
ses,
con
sult
ati
on
s, h
osp
italis
ati
on
s or
de
ath
s
Initiation Acceleration Peak Declining
Animated slide: Please wait
One possible European scenario — summer 2009
In reality, the initiation phase can be prolonged, especially in the summer months. What cannot be determined is when acceleration takes place.
0%
5%
10%
15%
20%
25%
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Month
Pro
port
ion
of
tota
l ca
ses,
con
sult
ati
on
s, h
osp
italis
ati
on
s or
death
s
Initiation Acceleration Peak Declining
Animated slide: Press key
Apr
Switch to deaths
Some ‘Lessons Learnt ‘ points Five years preparation paid off – for those who did it
But need to operationalise and adapt the plans for this pandemic
The ‘acid tests’ have been crucial e.g. can you distribute antivirals quickly and efficiently ?http://ecdc.europa.eu/en/healthtopics/Pages/Pandemic_Influenza_Assessment_Tools.aspx
Built around a regularly updated risk assessment http://ecdc.europa.eu/en/healthtopics/Documents/0907_Influenza_AH1N1_Risk_Assessment.pdf
Planning projections has to be adjusted http://ecdc.europa.eu/en/healthtopics/Documents/0908_InfluenzaA_H1N1_Planning_Assumptions_for_the_First_Wave_of_Pandemic_A(H1N1)_2009_in_Europe.pdf
Surveillance has had to be adjusted http://ecdc.europa.eu/en/publications/Publications/0908_MER_Surveillance_and_Studies_in_a_Pandemic_Meeting_Report.pdf
Personal interventions - are justified Societal Public Health Interventions – mostly not justified
http://ecdc.europa.eu/en/publications/Publications/0906_TER_Public_Health_Measures_for_Influenza_Pandemics.pdf http://ecdc.europa.eu/en/healthtopics/Documents/0908_InfluenzaA_H1N1_Managing_schools_during_the_current_pandemic_(H1N1)_2009.pdf
Containment vs. Mitigation – beware of policy decisions http://ecdc.europa.eu/en/healthtopics/Documents/0906_Influenza_AH1N1_Mitigation_and_Delaying_Strategies_for_the_Influenza_in_Europe.pdf
Beware of stating numbers – deaths are difficult
The health care sector is a vulnerable point
RCGP (England and Wales) ILI consultation rate per 100,000 2008/09
and recent seasons.
0
50
100
150
200
250
40 42 44 46 48 50 52 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38
Week
Rat
e p
er 1
00 0
00 p
op
ula
tio
n
2008/09
2007/08
1999/00
Baseline Activity (<30 per 100,000)
Normal seasonal activity
(30-200 per 100,000)
Epidemic activity (>200 per 100,000)
First UK cases
detected
Treatment only phase
NPFS launched and schools closed for summer holidays
Some revised planning assumptions for the pandemic – first wave A(H1N1) 2009These represent a reasonable worst case applying to one European country (the
United Kingdom) with data available as of July 2009 They should not be used for
predictions Source: UK
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_102892
Clinical attack rate 30%
Peak clinical attack rate 6.5% (local planning assumptions 4.5% to 8%) per
weekComplication rate 15% of clinical cases
Hospitalisation rate 2% of clinical cases
Case fatality rate 0.1% to 0.2% (cannot exclude up to 0.35%) of clinical cases
Peak Absence Rate 12% of workforce
Some ‘Lessons Learnt ‘ points Five years preparation paid off – for those who did it
But need to operationalise and adapt the plans for this pandemic
The ‘acid tests’ have been crucial e.g. can you distribute antivirals quickly and efficiently ?http://ecdc.europa.eu/en/healthtopics/Pages/Pandemic_Influenza_Assessment_Tools.aspx
Built around a regularly updated risk assessment http://ecdc.europa.eu/en/healthtopics/Documents/0907_Influenza_AH1N1_Risk_Assessment.pdf
Planning projections has to be adjusted http://ecdc.europa.eu/en/healthtopics/Documents/0908_InfluenzaA_H1N1_Planning_Assumptions_for_the_First_Wave_of_Pandemic_A(H1N1)_2009_in_Europe.pdf
Surveillance has had to be adjusted http://ecdc.europa.eu/en/publications/Publications/0908_MER_Surveillance_and_Studies_in_a_Pandemic_Meeting_Report.pdf
Personal interventions - are justified Societal Public Health Interventions – mostly not justified
http://ecdc.europa.eu/en/publications/Publications/0906_TER_Public_Health_Measures_for_Influenza_Pandemics.pdf http://ecdc.europa.eu/en/healthtopics/Documents/0908_InfluenzaA_H1N1_Managing_schools_during_the_current_pandemic_(H1N1)_2009.pdf
Containment vs. Mitigation – beware of policy decisions http://ecdc.europa.eu/en/healthtopics/Documents/0906_Influenza_AH1N1_Mitigation_and_Delaying_Strategies_for_the_Influenza_in_Europe.pdf
Beware of stating numbers – deaths are difficult
The health care sector is a vulnerable point
Daily and Weekly hospitalisations with suspected pandemic influenza
in England, by age group.
0
1
2
3
4
5
6
Thu 16 Jul Thu 23 Jul Thu Jul Thu 06 Aug Thu 13 Aug
Day
Rat
e p
er 1
00,0
00
<5 5-15
16-64 65+
Total
Age Group 30 31 32
<5 442 (15.0) 312 (10.6) 184 (6.2)
5-15 195 (2.9) 112 (1.7) 72 (1.1)
16-64 799 (2.4) 667 (2.0) 505 (1.5)
65+ 229 (2.8) 208 (2.6) 147 (1.8)
Total 1665 (3.3) 1299 (2.6) 908 (1.8)
Weekly number (rate per 100,000 population) of new hospitalisations
Daily rate per 100,000 population of new hospitalisations.
Hospitalised patientsEngland
Age group (years)
< 5 5-15 16-64 65+ Total
Total number of patients
in hospital
46 25 227 73 371
Number of
patients in critical
care
2 0 31 6 39
At 12 August 0800
At 12 August 0800
0
1
2
3
4
5
6
<5 5 to 15 16 to 64 65+
Age group (years)
Num
ber
of p
eopl
e in
hos
pita
l per
100
,000
pop
ulat
ion
of t
hat
age
15th July
22nd July
29th July
5th August
12th August
Hospitalisation ratiosper 100,000 population of that age
Some ‘Lessons Learnt ‘ points Five years preparation paid off – for those who did it
But need to operationalise and adapt the plans for this pandemic
The ‘acid tests’ have been crucial e.g. can you distribute antivirals quickly and efficiently
Built around a regularly updated risk assessment
Planning projections has to be adjusted
Surveillance has had to be adjusted Personal interventions - are justified
Societal Public Health Interventions – mostly not justified
Containment vs. Mitigation – beware of policy decisions
Beware of stating numbers – deaths are difficult
The health care sector is a vulnerable point